There is a big need for therapeutic advancement in the rare disease community – however, public markets are stifling innovation and development for advanced medicines. This webinar, on Thursday, September 15th, will examine the current markets, their effect on the innovation in rare disease drug development, and what we can do to help.
Sponsored by Precision ADVANCE, this panel features insights from industry leaders on their organization’s pipeline, the advanced therapy investment landscape, and the innovation, manufacturing, and community needs to successfully bring an advanced therapy to market. This discussion will be moderated by Anshul Mangal (President, Project Farma & Precision ADVANCE), and include insights from Alex Karnal (Founder, Braidwell), Chidozie Ugwumba (Managing Partner, Symbiosis), James Wilson (Director, Perelman School of Medicine, UPenn), and Tony Khoury (EVP, Project Farma).
Key points to be discussed:
- Learn about the current state of investments for the rare disease sector
- Understand the market’s effect on innovation in rare disease
- Hear from leading experts on what we do as a community to help drive innovation forward